EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients

EGFR mutation must be investigated in HIV-NSCLC cases due to its predictive and prognostic impact, whereas KRAS mutation is of poor prognostic value. Clinicians should search for drugs dedicated to this target population.